Janumet Xr

Active Ingredient(s): Sitagliptin + Metformin Hydrochloride
FDA Approved: * February 2, 2012
Pharm Company: * MERCK SHARP DOHME
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Janumet Xr Overview

Sitagliptin/metformin, sold under the brand name Janumet among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes.[6] It may be used in those whose blood sugar is not controlled with metformin and a sulfonylurea.[6][7] It is taken by mouth.[6] Common side effects include diarrhea, headache, and upper respiratory tract infections.[1] Serious side effects may include lactic ac...

Read more Janumet Xr Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sitagliptin/metformin

Recent Janumet Xr Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sitagliptin + Metformin Hydrochloride
  • Tablet, Extended Release: 100mg + 1000mg, 1gm + 100mg, 1gm + 50mg, 500mg + 50mg, 50mg + 1000mg, 50mg + 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Janumet Xr: (4 results)

Sorted by National Drug Code
  • 0006-0078 Janumet XR 50/500 24 Hr Extended Release Tablet by Merck Sharp & Dohme Corp.
  • 0006-0080 Janumet XR 50/1000 24 Hr Extended Release Tablet by Merck Sharp & Dohme Corp.
  • 0006-0081 Janumet XR 100/1000 24 Hr Extended Release Tablet by Merck Sharp & Dohme Corp.
  • 50090-4411 Janumet Oral Tablet, Film Coated, Extended Release by A-s Medication Solutions

Drugs with one or more similar ingredients: (32 results)